Skip to main content
The Breast Cancer Research Scandal: Addressing the Issues
Canadian Medical Association Journal (1995)
  • Charles Weijer, McGill University

The three claims put forward by Dr. Roger Poisson to rationalize his enrollment of ineligible subjects in clinical trials do not justify research fraud. None the less, certain lessons for the conduct of clinical research can be learned from the affair: experimental therapies should be made available to technically ineligible subjects when no effective therapy exists for their disease; further research must investigate the possible benefits of clinical-trial participation; broadly based, pragmatic trials must be regarded as the ideal model; and each eligibility criterion in a clinical-trial protocol should be justified.

  • Medical Ethics,
  • Randomized Controlled Trials,
  • Scientific Misconduct
Publication Date
April 15, 1995
Publisher Statement
Dr. Charles Weijer is currently a faculty member of The University of Western Ontario.
Citation Information
Charles Weijer. "The Breast Cancer Research Scandal: Addressing the Issues" Canadian Medical Association Journal Vol. 152 Iss. 8 (1995)
Available at: